Published

The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Current Psychiatry Research and Reviews
Date: 2022-05-15
Source: OpenAlex
DOI: 10.2174/2666082218666220513142002
PubMed: Unavailable

Authors

Andrew Hodge Suporn Sukpraprut-Braaten Robert Strayhan

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Receptor Pharmacology Clinical Trial Randomized Controlled Trial Meta-Analysis Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions2026-07-02 The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis2022-05-15

Related papers

COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2026-01-01 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Expert review of clinical pharmacology · 2018-09-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01